(Q43611735)

English

Liquid chromatographic-tandem mass spectrometric determination of amprenavir (agenerase) in serum/plasma of human immunodeficiency virus type-1 infected patients receiving combination antiretroviral therapy

scientific article published in April 2001

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Liquid chromatographic-tandem mass spectrometric determination of amprenavir (agenerase) in serum/plasma of human immunodeficiency virus type-1 infected patients receiving combination antiretroviral therapy (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

author name string

Gunawan S

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Griswold MP

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Kahn DG

3

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

language of work or name

0 references

publication date

1 April 2001

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Journal of Chromatography

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

914

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

1-2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

1-4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Amprenavir : A Viewpoint by Walter T. Hughes

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2900607-0

7 January 2021

The effect of high-dose saquinavir on viral load and CD4+ T-cell counts in HIV-infected patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2900607-0

7 January 2021

Toxicity, efficacy, plasma drug concentrations and protease mutations in patients with advanced HIV infection treated with ritonavir plus saquinavir. Swiss HIV Cohort Study

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2900607-0

7 January 2021

Indinavir concentrations and antiviral effect

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2900607-0

7 January 2021

The relationship between ritonavir plasma levels and side-effects: implications for therapeutic drug monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2900607-0

7 January 2021

Simultaneous quantitative determination of the HIV protease inhibitors amprenavir, indinavir, nelfinavir, ritonavir and saquinavir in human plasma by ion-pair high-performance liquid chromatography with ultraviolet detection

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2900607-0

7 January 2021

Simultaneous determination of the HIV protease inhibitors indinavir, amprenavir, saquinavir, ritonavir, nelfinavir and the non-nucleoside reverse transcriptase inhibitor efavirenz by high-performance liquid chromatography after solid-phase extractio

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2900607-0

7 January 2021

Sensitive liquid chromatographic assay for amprenavir, a human immunodeficiency virus protease inhibitor, in human plasma, cerebrospinal fluid and semen

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2801%2900607-0

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0021-9673(01)00607-0

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43611735&oldid=2101889141"